Business

INV043 SIGNIFICANTLY IMPROVED CHECKPOINT INHIBITOR THERAPY

INV043 SIGNIFICANTLY IMPROVED CHECKPOINT INHIBITOR THERAPY

Invion Ltd.May 29, 20225

INV043 SIGNIFICANTLY IMPROVED CHECKPOINT INHIBITOR THERAPY

About this update from Invion Ltd.

Invion Ltd has released a press release. View Attachment

View stock analysis, news, and events for Invion Ltd.

More from Invion Ltd.

Appendix 4C and Quarterly Activities Report - June 2026

July 30, 2026

Photosoft Platform Expands to Eye Diseases Via Partnership

May 18, 2026

All Invion Ltd. news →